Operational cash flow remains strong with an OCF/NI ratio of 0.95 in 2026Q4, supporting a disciplined capital allocation strategy that saw $20.2M directed toward share buybacks.
| Metric | Mar'26 | Mar'25 | Mar'24 | Mar'23 | Mar'22 | Mar'21 | Mar'20 | Mar'19 | Mar'18 | Mar'17 | Mar'16 | Mar'15 | Mar'14 | Mar'13 | Mar'12 | Mar'11 | Mar'10 | Mar'09 | Mar'08 | Mar'07 | Mar'06 | Mar'05 | Mar'04 | Mar'03 | Mar'02 | Mar'01 | Mar'00 | Mar'99 | Mar'98 | Mar'97 |
|---|
| Cash from Operations | 155.64B | 127.31M | 99.24M | 82.29M | 67.22M | 94.38M | 80.83M | 78.64M | 62.15M | 52.05M | 51.31M | 44.32M | 54.8M | 54.82M | 36.21M | 48.65M | 38.29M | 31.31M | 37.27M | 29.99M | 28.74M | 26.36M | 25.69M | 22.25M | 26.58M | 23.77M | 12.72M | 10.2M | 11.3M | 12.1M |
| Operating CF Growth % | 122147.97% | 28.29% | 20.6% | 22.41% | -28.77% | 16.77% | 2.78% | 26.53% | 19.4% | 1.44% | 15.78% | -19.13% | -0.03% | 51.4% | -25.57% | 27.07% | 22.3% | -15.99% | 24.26% | 4.34% | 9.06% | 2.59% | 15.47% | -16.29% | 11.83% | 86.85% | 24.7% | -9.73% | -6.61% | 68.06% |
| Operating CF / Revenue % | 16237.41% | 14.22% | 12.48% | 11.45% | 10.4% | 17.08% | 13.65% | 13.2% | 11.13% | 10.04% | 10.19% | 9% | 11.44% | 12.77% | 8.77% | 12.78% | 11.33% | 10.1% | 12.34% | 10.92% | 10.79% | 9.06% | 8.41% | 7.87% | 11.27% | 11.34% | 6.81% | 6.16% | 7.97% | 9.94% |
| Net Income | 110.34B | 95.17M | 76.25M | 66.36M | 66.41M | 46.36M | 47.38M | 46.7M | 35.7M | 29.48M | 28.52M | 28.59M | 34.39M | 26.73M | 26.55M | 24.66M | 26.1M | 19.28M | 23.38M | 18.58M | 9.75M | 10.16M | 16.01M | 16.58M | 14.82M | 13.22M | 11.97M | 10.4M | 9.5M | 8.5M |
| Depreciation & Amortization | 31.76B | 29.54M | 26.25M | 25.12M | 23.92M | 23.44M | 22.52M | 22.98M | 21.77M | 20.95M | 19.95M | 18M | 16.41M | 15.74M | 14.72M | 12.25M | 11.99M | 11.78M | 11.77M | 10.12M | 10.94M | 11.09M | 9.96M | 9.34M | 8.41M | 6.76M | 6.96M | 6.3M | 5.3M | 4.2M |
| Stock-Based Compensation | 5.41B | 5.71M | 4.98M | 5.56M | 5.2M | 4.98M | 4.49M | 4.35M | 3.16M | 2.43M | 2.19M | 2.21M | 2.14M | 997K | 2.28M | 2.54M | 2.1M | 1.33M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 4.78B | -5.16M | -3.32M | -1.91M | 2.3M | -8.38M | 1.47M | 1.46M | -874K | -1.22M | -1.66M | 304K | -2.52M | 2.28M | 9.05M | 624K | 308K | 2K | -2.23M | -1.52M | -1.47M | 1.79M | 1.33M | 999K | -40K | 303K | -131K | -600K | 100K | 400K |
| Other Non-Cash Items | 3.34B | 3.89M | 2.12M | 1.63M | 280K | 2.61M | 1.75M | 2.18M | 3.76M | 3.07M | 1.64M | 2.02M | 1.41M | 2.54M | 2.89M | 6.18M | 2.92M | 2.54M | 4.08M | 4.28M | 4.16M | 3.47M | -42K | 2.77M | 52K | -45K | 192K | -100K | 200K | 200K |
| Working Capital Changes | 2.52M | -1.83M | -7.05M | -14.47M | -30.88M | 25.37M | 3.22M | 966K | -1.37M | -2.65M | 655K | -6.8M | 2.97M | 6.54M | -19.29M | 2.39M | -5.13M | -3.62M | 260K | -1.47M | 5.37M | -140K | -1.57M | -7.44M | 3.33M | 3.53M | -6.27M | -5.8M | -3.8M | -1.2M |
| Cash from Investing | -45.36B | -35.76M | -29.24M | -26.32M | -29.82M | -17.24M | -32.36M | -15.27M | -27.69M | -31.01M | -17.36M | -24.27M | -18.34M | -14.89M | -23.26M | -19.74M | -12.27M | -13.85M | -29.34M | -20.5M | -7.75M | -11.64M | -17.35M | -17.32M | -10.88M | -10.15M | -6.24M | -6.6M | -8.7M | -5.8M |
| Capital Expenditures | -45.36B | -35.76M | -29.24M | -26.32M | -29.82M | -17.24M | -32.36M | -15.27M | -27.69M | -31.04M | -16.76M | -22.87M | -18.34M | -14.89M | -23.21M | -18.5M | -11.67M | -10.48M | -14.76M | -8.53M | -7.75M | -11.56M | -13.12M | -13.93M | -10.88M | -10.15M | -6.24M | -6.6M | -8.7M | -5.8M |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -45K | -1.24M | -600K | -3.37M | -14.59M | -11.97M | 0 | -80K | -4.23M | -3.4M | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchase of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sale/Maturity of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34K | -600K | -1.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -47.8B | -26.54M | -35.76M | -82.14M | -79.61M | -20.64M | -56.96M | -27.42M | -7.3M | -25.21M | -26.69M | -29.4M | -21.41M | -26.71M | -18.62M | -26.88M | -28.77M | -20.69M | -5.03M | -8.67M | -15.73M | -14.41M | -7.65M | -11.61M | -12.56M | -9.8M | -9.89M | -3M | -9.8M | -7.7M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -56.21M | -37.6M | -45.71M | -93.67M | -90.08M | -32.67M | -65.61M | -35.17M | -11.19M | -28M | -31.52M | -31.8M | -27.18M | -30.73M | -21.64M | -30.61M | -32.56M | -23.46M | -8.21M | -21.89M | -18.72M | -17.2M | -12.15M | -14.99M | -15.24M | -13.95M | -12.97M | -5.3M | -12.3M | -9.5M |
| Stock Issued | 8.41M | 0 | 0 | 0 | 0 | 0 | 0 | 7.74M | 3.88M | 2.79M | 4.12M | 2M | 3.73M | 3.71M | 2.56M | 4.73M | 2.73M | 2.14M | 2.84M | 9.62M | 3M | 2.79M | 4.51M | 3.38M | 2.68M | 4.15M | 3.08M | 2.3M | 2.5M | 1.7M |
| Debt Issuance (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1000K | -1000K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -47.75B | 11.07M | 9.95M | 11.53M | 10.47M | 12.03M | 8.65M | 7.74M | 3.88M | 2.79M | 4.83M | 2.4M | 5.77M | 4.02M | 459K | -1M | 3.79M | 2.77M | 340K | 3.59M | 0 | 0 | 12.15M | 14.99M | 0 | 0 | 0 | 0 | 0 | 100K |
| Net Change in Cash | 62.49B | 65.02M | 34.23M | -26.18M | -42.21M | 56.49M | -8.49M | 35.94M | 27.16M | -4.17M | 7.26M | -9.35M | 15.04M | 13.22M | -5.67M | 2.03M | -2.98M | -3.23M | 2.89M | 814K | 5.26M | 304K | 2.73M | -6.69M | 3.14M | 3.81M | -3.41M | 600K | -7.2M | -1.4M |
| Exchange Rate Effect | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash at Beginning | 170.58B | 105.56M | 71.33M | 97.5M | 139.72M | 83.22M | 91.71M | 55.77M | 28.61M | 32.78M | 25.52M | 34.87M | 19.82M | 6.6M | 12.27M | 10.24M | 13.22M | 17.91M | 15.02M | 14.21M | 8.95M | 8.64M | 5.91M | 12.6M | 9.46M | 5.64M | 9.05M | 8.4M | 15.7M | 17.1M |
| Cash at End | 233.07B | 170.58M | 105.56M | 71.33M | 97.5M | 139.72M | 83.22M | 91.71M | 55.77M | 28.61M | 32.78M | 25.52M | 34.87M | 19.82M | 6.6M | 12.27M | 10.24M | 14.68M | 17.91M | 15.02M | 14.21M | 8.95M | 8.64M | 5.91M | 12.6M | 9.46M | 5.64M | 9M | 8.5M | 15.7M |
| Free Cash Flow | 110.28B | 91.56M | 70M | 55.97M | 37.4M | 77.14M | 48.47M | 63.37M | 34.46M | 21.01M | 34.55M | 21.45M | 36.46M | 39.93M | 12.46M | 26.56M | 26.62M | 20.82M | 22.51M | 21.46M | 20.99M | 14.79M | 12.57M | 8.32M | 15.7M | 13.61M | 6.48M | 3.6M | 2.6M | 6.3M |
| FCF Growth % | 120348.89% | 30.81% | 25.07% | 49.64% | -51.51% | 59.15% | -23.51% | 83.86% | 64.02% | -39.2% | 61.11% | -41.17% | -8.7% | 220.53% | -53.09% | -0.23% | 27.82% | -7.49% | 4.9% | 2.23% | 41.87% | 17.73% | 51.06% | -47.01% | 15.35% | 110.08% | 79.97% | 38.46% | -58.73% | 293.75% |
| FCF Margin % | 11505.47% | 10.22% | 8.8% | 7.79% | 5.79% | 13.96% | 8.18% | 10.64% | 6.17% | 4.05% | 6.86% | 4.35% | 7.61% | 9.3% | 3.02% | 6.98% | 7.88% | 6.72% | 7.46% | 7.82% | 7.88% | 5.08% | 4.12% | 2.94% | 6.66% | 6.5% | 3.47% | 2.18% | 1.83% | 5.18% |
| FCF per Share | 2.14K | 1.76 | 1.35 | 1.06 | 0.69 | 4.16 | 2.61 | 3.33 | 1.81 | 1.07 | 1.73 | 1.03 | 0.57 | 0.54 | 0.17 | 0.36 | 0.36 | 0.28 | 0.27 | 0.25 | 0.24 | 0.16 | 0.13 | 0.09 | 0.15 | 0.13 | 0.06 | 0.03 | 0.02 | 0.05 |
Medical labor cost inflation
As evidenced by the quarterly data, CorVel exhibits significant seasonal fluctuations in operating cash flow, with the OCF/NI ratio swinging from a low of 0.78 in 2024Q4 to a peak of 2.02 in 2026Q1, highlighting the inherent timing differences between service delivery and cash collection.
The wide variance in the OCF/NI ratio suggests that cash conversion is highly sensitive to the timing of large-scale claims settlements and the associated administrative fee realization. Investors should interpret these swings as a reflection of the company's transactional revenue model rather than a fundamental deterioration in the underlying cash-generating capacity of the CareMC platform.
According to the provided financial records, quarterly claims payments have steadily trended upward from $160.1M in 2024Q3 to $185.5M in 2026Q4, indicating a consistent expansion in the volume of medical bills processed through the company's proprietary network and managed care infrastructure.
This upward trajectory in claims payments appears to correlate with broader medical inflation and increased utilization of the company's services. The steady growth in these outflows warrants monitoring, as it may imply higher administrative burdens that require ongoing automation to maintain current operating margins.
Based on reported figures, CorVel has consistently utilized excess cash to fund share repurchases, with buyback activity reaching $20.2M in 2026Q4, demonstrating a clear management preference for returning capital to shareholders over pursuing large-scale, potentially dilutive acquisitions in the competitive TPA landscape.
The company's ability to fund these repurchases entirely from operating cash flow without incurring debt underscores the strength of its balance sheet. This strategy appears to provide a floor for shareholder value, though it may also suggest a lack of high-return internal reinvestment opportunities beyond current software development initiatives.
As shown in the historical data, the company maintains a strong alignment between net income and operating cash flow, with the OCF/NI ratio frequently exceeding 1.0, which suggests that reported earnings are supported by actual cash inflows rather than non-cash accruals or aggressive accounting practices.
The consistent ability to generate cash in excess of net income indicates high earnings quality and effective management of working capital. This trend may imply that the company's revenue recognition policies are conservative and that the underlying business model remains fundamentally sound despite the inherent volatility of the insurance services sector.
Quick answers to the most common questions about buying CRVL stock.
CorVel Corporation (CRVL) generated $155.64B in net cash from operating activities in 2026. This reflects the cash generated directly from core business operations.
CorVel Corporation (CRVL) generated $110.28B in free cash flow in 2026. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
CorVel Corporation (CRVL) spent $45.36B on capital expenditures in 2026. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2026, CorVel Corporation (CRVL) spent $56.2M on share repurchases. This shows the company's commitment to returning capital to its equity investors.